Short Trade Idea
Enter your short position between $119.68 (the intra-day low of its latest bullish candlestick) and $123.70 (yesterday’s intra-day high).
Market Index Analysis
Merck & Co (MRK) is a member of the Dow Jones Industrial Average, the S&P 100 Index, and the S&P 500 Index.
All three indices trade inside bearish chart patterns with rising bearish trading volumes.
The Bull Bear Power Indicator of the S&P 500 Indexis bearish with a descending trendline.
Market Sentiment Analysis
Equity markets plunged yesterday but recovered during the sessions as investors bought the dip. Equity futures suggest another plunge this morning, as the war with Iran escalates, and President Trump promised the most significant wave of attacks is yet to happen. Iran warned that the Strait of Hormuz is closed, and that any ship that attempts to cross it would be attacked. However, some ships are still getting across the Strait. Energy prices are rising, which could spike inflation and sink the global economy into a recession if the war lasts longer than feared. Earnings from Target will offer a snapshot of consumer health, and volatility should remain elevated.
Merck & Co Fundamental Analysis
Merck & Co is a multinational pharmaceutical company. It is a leader in cancer treatments, with vaccines and animal health products rounding out its top three revenue drivers.
So, why am I bearish on MRK following its earnings release?
I remain bearish on Merck & Co, driven by its 2026 revenue guidance miss, lower EPS guidance amid a $3.65 per share hit from its Cidara acquisition, and margin compression, with the outlook calling for margins of 19.2% in 2026 versus 34.6% in 2025. The Keytruda patent cliff threatens 50% of revenues, its current pipeline lacks candidates to replace Keytruda, and Gardasil continues to struggle. Insider selling and analyst downgrades add to concerns, along with government pressure to lower drug costs.
Metric | Value | Verdict |
P/E Ratio | 16.68 | Bullish |
P/B Ratio | 5.71 | Bearish |
PEG Ratio | 3.69 | Bearish |
Current Ratio | 1.54 | Bearish |
ROIC-WACC Ratio | Positive | Bullish |
Merck & Co Fundamental Analysis Snapshot
The price-to-earning (P/E) ratio of 16.68 makes MRK an inexpensive stock. By comparison, the P/E ratio for the S&P 500 Index is 29.57.
The average analyst price target for MRK is $127.21, suggesting negligible upside potential, while downside risks are accumulating.
Merck & Co Technical Analysis
Today’s MRK Signal
Merck Price Chart
The MRK D1 chart shows price inside a horizontal resistance zone.
It also shows price action between its ascending 0.0% and 38.2% Fibonacci Retracement Fan levels.
The Bull Bear Power Indicator is bullish with a negative divergence.
The average bearish trading volumes are higher than the average bullish trading volumes.
MRK flatlined as the S&P 500 Index corrected, a bullish confirmation, but breakdown catalysts are rising.
My MRK Short Stock Trade
MRK Entry Level: Between $119.68 and $123.70
MRK Take Profit: Between $82.01 and $87.26
MRK Stop Loss: Between $135.84 and $138.61
Risk/Reward Ratio: 2.33
Ready to trade our analysis of Merck? Here is our list of the best stock brokers worth reviewing.